Purpose of the Procedure
- To determine if the fetus is Rhesus D positive or negative.
- To avoid unnecessary Anti-D immunoglobulin injections for the mother if the fetus is Rh-negative.
- To prevent Hemolytic Disease of the Fetus and Newborn (HDFN).
Book Fetal RHD Genotyping in Saudi Arabia | Lahalak Medical Platform
This advanced non-invasive test helps Rh-negative mothers determine fetal blood group status accurately, minimizing unnecessary anti-D injections and ensuring a personalized, safe clinical management plan during your pregnancy journey.
Scientific name: Non-Invasive Fetal RHD Genotyping
A sophisticated laboratory test using cell-free fetal DNA from maternal blood to determine Rhesus D status. It aims to prevent unnecessary anti-D immunoglobulin administration and manage potential hemolytic risks effectively.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Venous blood sample collection
- Cell-free fetal DNA analysis
- Detailed medical results report
Medical Service Information
Target Groups
- Pregnant women with Rh-negative blood type.
- Mothers seeking to minimize unnecessary medical interventions.
- High-risk pregnancies requiring precise immunological management.
Benefits of the Test
- High accuracy rate exceeding 99%.
- Completely non-invasive and safe for both mother and baby.
- Reduces healthcare costs and unnecessary pharmaceutical exposure.
Conditions & Notices
- Typically performed after the 10th week of pregnancy
- Specifically for Rh-negative pregnant women
Medical services you might also like
